Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koller, M. R.
Right arrow Articles by Palsson, B. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koller, M. R.
Right arrow Articles by Palsson, B. O.
Stem Cells, Vol. 15, No. 4, 305-313, July 1997
© 1997 AlphaMed Press

Importance of Parenchymal:Stromal Cell Ratio for the Ex Vivo Reconstitution of Human Hematopoiesis

Manfred R. Kollera, Ilana Manchel, Bernhard Ø. Palssonb

Aastrom Biosciences, Inc., Ann Arbor, Michigan, USA;
a Present address: Advanced Tissue Sciences, Inc., La Jolla, California, USA;
b Department of Bioengineering, University of California-San Diego, La Jolla, California, USA

Key Words. Cell therapy • Tissue engineering • Bone marrow • Hematopoiesis • Stem cells • Stroma

Dr. Manfred R. Koller, c/o Aastrom Biosciences, Inc., P.O. Box 376, Ann Arbor, MI 48106, USA.

Many new developments in tissue engineering rely on the culture of primary tissues which is composed of parenchymal and mesenchymal (stromal) cell populations. Because stroma regulates parenchymal function, the parenchymal:stromal cell (P:S) ratio will likely influence culture behavior. To investigate parenchymal-stromal cell interactions, the P:S ratio was systematically varied in a human bone marrow (BM) culture system, measuring the output of mature cells, immature progenitors (colony forming units-granulocyte/macrophage [CFU-GM]), and primitive stem cells (long-term culture-initiating cells [LTC-IC]). When parenchymal CD34-enriched cells were grown without stroma, cell and CFU-GM output increased linearly as inoculum density was increased, resulting in constant cell and CFU-GM expansion ratios. On irradiated preformed stroma (IPFS), culture output was significantly higher and less dependent on CD34-enriched cell inoculum density, resulting in greater expansion ratios at lower inoculum densities. The number of IPFS cells required to support CD34-enriched cells was independent of the CD34-enriched cell number, suggesting that IPFS did not provide discrete niches, but instead acted through soluble signals. Experiments using conditioned medium (CM) from IPFS confirmed the presence of soluble signals, but CM did not completely substitute for direct contact between CD34-enriched cells and IPFS. Because of known differences between IPFS and stroma growing within BM mononuclear cell (MNC) cultures, experiments were next performed using mixtures of CD34-enriched and CD34-depleted fractions of MNC. When inoculated with a fixed CD34+lin cell number, culture output was optimal near the P:S ratio of the unmanipulated MNC sample and declined as CD34 cell number was increased or decreased. In cultures inoculated with a fixed total cell number, CFU-GM output increased as CD34+lin cell number was increased, whereas LTC-IC output reached a plateau. These data suggest that a limited number of LTC-IC supportive niches were present in MNC stroma, whereas IPFS lacks these niches and acts predominantly through a less potent soluble mechanism. These studies underscore the importance of parenchymal-stromal cell interactions in the ex vivo reconstitution of tissue function and offer insight into the nature of these interactions in the human BM culture system.




This article has been cited by other articles:


Home page
BloodHome page
D. Baksh, J. E. Davies, and P. W. Zandstra
Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment
Blood, November 1, 2005; 106(9): 3012 - 3019.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-C. Shih, Y. Weng, A. Mamelak, T. LeBon, M. C.-T. Hu, and S. J. Forman
Identification of a candidate human neurohematopoietic stem-cell population
Blood, October 15, 2001; 98(8): 2412 - 2422.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. W. Zandstra, D. A. Lauffenburger, and C. J. Eaves
A ligand-receptor signaling threshold model of stem cell differentiation control: a biologically conserved mechanism applicable to hematopoiesis
Blood, August 15, 2000; 96(4): 1215 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
T. Köhler, R. Plettig, W. Wetzstein, B. Schaffer, R. Ordemann, H.-O. Nagels, G. Ehninger, and M. Bornhäuser
Defining Optimum Conditions for the Ex Vivo Expansion of Human Umbilical Cord Blood Cells. Influences of Progenitor Enrichment, Interference with Feeder Layers, Early-Acting Cytokines and Agitation of Culture Vessels
Stem Cells, January 1, 1999; 17(1): 19 - 24.
[Abstract] [Full Text]


Home page
BloodHome page
M. R. Koller, I. Manchel, and A. K. Smith
Quantitative Long-Term Culture-Initiating Cell Assays Require Accessory Cell Depletion That Can Be Achieved by CD34-Enrichment or 5-Fluorouracil Exposure
Blood, June 1, 1998; 91(11): 4056 - 4064.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1997 by AlphaMed Press.